Live
- Beware of Fake RBI Voicemails Scam: How to Stay Safe
- Raj govt to allot land for hostel in Sahibzades' name: CM Sharma
- Anna University rape case: BJP says accused belongs to DMK student wing
- 'Dooradarshini' Brings the 90s to Life with a Nostalgic Love Story
- BJP Accuses Congress of Anti-India Politics After Distorted Map Displayed at CWC Venue
- ISL: Fluent Odisha face depleted Mohammedan in search of top four spot
- Afghanistan won't tolerate any aggression, warns Kabul after Pakistani airstrikes that killed 46
- India a global leader in disaster warning systems: Jitendra Singh
- India vs Australia 4th Test Day 1: Bumrah Shines as Australia Holds the Advantage at MCG
- Adani's Vizhinjam port welcomes 100th vessel within 6 months of operations
No approved treatments yet for COVID-19: WHO
The World Health Organization (WHO) said that a number of treatments are under clinical trials for the treatment of COVID-19, but none of those was yet approved.
Geneva: The World Health Organization (WHO) said that a number of treatments are under clinical trials for the treatment of COVID-19, but none of those was yet approved.
"There are hundreds of clinical trials that are underway, and the reason we need to wait for the results of these studies is because they are evaluating how these medicines, how these drugs work, in terms of either preventing infection, preventing someone from progressing to severe disease, preventing death and how safe they are, do they have any side effects," Maria Van Kerkhove, technical lead for the WHO's Health Emergencies Program, said on Friday in a press conference in Geneva, Xinhua news agency reported.
"Right now, WHO has launched the 'Solidarity Trial' which is a clinical trial focusing on some drugs, some therapeutics, to look at whether or not these are safe and effective for COVID-19. There are more than 2,500 patients enrolled in this multi-site clinical trial," she said.
"And it will take some time before we have full answers to which treatments work, but right now we don't have any approved treatments for COVID-19," she added.
Michael Ryan, executive director of the WHO Health Emergencies Program, stressed the importance of proper process to ensure safety.
"And there's a very very well tested process of doing this, so it's really important that we encourage innovation, we encourage people to be looking for solutions, but then as those solutions potentially become available, we need to put them through the proper process in the interest of safety, in the interest of efficacy and in order to make sure that we first do no harm," he said.
